Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Tecan Group Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tecan Group Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Techne Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Techne Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Arbutus Biopharma Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Arbutus Biopharma Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Telesso Technologies Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Telesso Technologies Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Telik Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Telik Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tempo Scan Pacific tbk PT Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tempo Scan Pacific tbk PT Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tengion, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tengion, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Terra Med Alliance Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Terra Med Alliance Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Teva Pharmaceutical Industries Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Teva Pharmaceutical Industries Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Thallion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Thallion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

The United Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

The United Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Themis Medicare Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Themis Medicare Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TheraBiogen Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TheraBiogen Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theratechnologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theratechnologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Theravance Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Theravance Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Thermo Fisher Scientific, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Thermo Fisher Scientific, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Threshold Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Threshold Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ThromboGenics NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ThromboGenics NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tian'an Pharmaceutical Co.Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tian'an Pharmaceutical Co.Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Chase Sun Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Chase Sun Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Lisheng Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Lisheng Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Ringpu Bio-Technology Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Ringpu Bio-Technology Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Tasly Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Tasly Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin TEDA Biomedical Engineering Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin TEDA Biomedical Engineering Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Tianyao Pharmaceutical Co.,Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Tianyao Pharmaceutical Co.,Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianjin Zhongxin Pharmaceutical Group Corporation Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tianyin Pharmaceutical Co., Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tianyin Pharmaceutical Co., Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tibet Cheezheng Tibetan Medicine Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tibet Cheezheng Tibetan Medicine Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tien Liang Biotech Co Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tien Liang Biotech Co Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TiGenix N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TiGenix N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tikcro Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tikcro Technologies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tissera Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tissera Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Factor Therapeutics Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Factor Therapeutics Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Titan Biotech Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Titan Biotech Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Titan Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Titan Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tong Ren Tang Technologies Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tong Ren Tang Technologies Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonghua Dongbao Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tongjitang Chinese Medicines Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tongjitang Chinese Medicines Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tongli Pharmaceuticals (USA), Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tongli Pharmaceuticals (USA), Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Tonira Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Tonira Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TopoTarget A/S Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TopoTarget A/S Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Topsun Science And Technology Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Topsun Science And Technology Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Torii Pharmaceutical Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Torii Pharmaceutical Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Torrent Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Torrent Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Towa Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Towa Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Trans Genic Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Trans Genic Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transcept Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transcept Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transchem Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transchem Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Transdel Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Transdel Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1